المؤلفون: James Larkin, Andrew F. Hill, Luis de la Cruz-Merino, Michael Millward, Jean-Jacques Grob, Mario Mandalà, Paola Queirolo, Leslie A. Fecher, Paolo A. Ascierto, Victoria Atkinson, Ivan Marquez-Rodas, Michele Maio, Petr Arenberger, Maurice Lobo, Jeffrey S. Weber, John T. Loffredo, Veerle de Pril, Stéphane Dalle, Michael Schenker, C. Lance Cowey, Michele Del Vecchio, Ana Arance, Helen Gogas, Marcus O. Butler, Vanna Chiarion-Sileni, Mark R. Middleton, Nikhil I. Khushalani

المصدر: The Lancet. Oncology. 21(11)

مصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Population, Phases of clinical research, Ipilimumab, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, Clinical endpoint, Adjuvant therapy, Medicine, Humans, CTLA-4 Antigen, education, Melanoma, Aged, Neoplasm Staging, education.field_of_study, Intention-to-treat analysis, business.industry, Hazard ratio, Antibodies, Monoclonal, Middle Aged, 030104 developmental biology, Nivolumab, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3a89263129a0d4750874cb8a261499Test
https://pubmed.ncbi.nlm.nih.gov/34592191Test

المؤلفون: Matthias Augustin, Jennifer Frueh, Kristian Reich, J. Sullivan, Petr Arenberger, S. Jazayeri, Boni E. Elewski, Ulrich Mrowietz, P. Regnault, R. You

المصدر: The British journal of dermatologyReferences. 184(3)

مصطلحات موضوعية: medicine.medical_specialty, Dermatology, Placebo, Antibodies, Monoclonal, Humanized, Severity of Illness Index, law.invention, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Quality of life, Randomized controlled trial, Double-Blind Method, law, Psoriasis, medicine, Clinical endpoint, Humans, business.industry, medicine.disease, Clinical trial, Treatment Outcome, Quality of Life, Secukinumab, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a90c728e511d075f86013715a749629Test
https://pubmed.ncbi.nlm.nih.gov/32479641Test

المؤلفون: Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Guminski, Grant R Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Enrique Fein, Michael Brown, Andrew Haydon, Adnan Khattak, Catriona McNeil, Phillip Parente, Jeremy Power, Rachel Roberts-Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas Berger, Ahmad Awada, Nathalie Blockx, Veronique Buyse, Jeroen Mebis, Fábio André Franke, Sérgio Jobim de Azevedo, Nicolas Silva Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa Petrella, Kerry Savage, Xinni Song, Ralph Wong, Nina Dabelic, Stjepko Plestina, Zeljko Vojnovic, Petr Arenberger, Ivo Kocak, Ivana Krajsova, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchova, Kadri Putnik, Brigitte Dreno, Caroline Dutriaux, Jean-Jacques Grob, Pascal Joly, Jean-Philippe Lacour, Nicolas Meyer, Laurent Mortier, Luc Thomas, Michael Fluck, Thilo Gambichler, Jessica Hassel, Axel Hauschild, Paul Donnellan, John McCaffrey, Derek Power, Samuel Ariad, Gil Bar-Sela, Daniel Hendler, Ilan Ron, Jacob Schachter, Paolo Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Paula Ferreira, Georgy Gafton, Yulia Makarova, Zoran Andric, Nada Babovic, Darjana Jovanovic, Lidija Kandolf Sekulovic, Graham Cohen, Lydia Dreosti, Daniel Vorobiof, Maria Teresa Curiel Garcia, Roberto Diaz Beveridge, Margarita Majem Tarruella, Ivan Marquez Rodas, Jose-M Puliats Rodriguez, Antonio Rueda Dominguez, Marianne Maroti, Karin Papworth, Olivier Michielin, Ewan Brown, Pippa Corrie, Mark Harries, Satish Kumar, Agustin Martin-Clavijo, Mark Middleton, Poulam Patel, Toby Talbot, Sanjiv Agarwala, Paul Chapman, Robert Conry, Gary Doolittle, Tara Gangadhar, Sigrun Hallmeyer, Omid Hamid, Leonel Hernandez-Aya, Douglas Johnson, Frederic Kass, Tatjana Kolevska, Scott Lunin, April Salama, Branimir Sikic, Bradley Somer, David Spigel, Eric Whitman

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, mutation-positive melanoma, Population, Placebo, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, medicine, education, Vemurafenib, Survival analysis, vemurafenib, BRAFV600, mutation-positive melanoma, education.field_of_study, Settore MED/35 - Malattie Cutanee e Veneree, business.industry, Hazard ratio, Regimen, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, BRAFV600, Cohort, vemurafenib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ca377ad3c682462789b57095f06c16Test
http://hdl.handle.net/11379/501841Test

المؤلفون: Andrea Vaclavkova, Paul-Gunther Sator, Péter Holló, Daniele D'Ambrosio, Sergio Chimenti, Petr Arenberger, Mylene Stefani, Michel Burcklen

المصدر: The Lancet. 384:2036-2045

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Administration, Oral, Phases of clinical research, General Medicine, Placebo, law.invention, Surgery, Thiazoles, Treatment Outcome, Double-Blind Method, Tolerability, Randomized controlled trial, Ponesimod, Maintenance therapy, Psoriasis Area and Severity Index, law, Internal medicine, Chronic Disease, Clinical endpoint, Humans, Psoriasis, Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121d38c67e2504ec6042cfae43bebbbfTest
https://doi.org/10.1016/s0140-6736Test(14)60803-5

المؤلفون: Petr Arenberger, Diamant Thaçi, M. Afonso, N Hattebuhr, Külli Kingo, G. Wuerth, J. Poetzl, H. Woehling, Sascha Gerdes, G Pulka, Cem Griffiths, J. Weglowska

المصدر: The British journal of dermatology. 176(4)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Injections, Subcutaneous, Dermatology, Drug Administration Schedule, Etanercept, law.invention, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, Psoriasis Area and Severity Index, law, Psoriasis, Internal medicine, Clinical endpoint, Medicine, Humans, Dosing, Adverse effect, Biosimilar Pharmaceuticals, 030203 arthritis & rheumatology, business.industry, Drug Substitution, medicine.disease, Antibodies, Neutralizing, Confidence interval, Surgery, Treatment Outcome, Chronic Disease, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72846baea578d6fec77f1f101e5f70c0Test
https://pubmed.ncbi.nlm.nih.gov/27787890Test

المؤلفون: Pierre-Dominique Ghislain, Sergio Chimenti, Diamant Thaçi, J-H. Saurat, A Khemis, K. Unnebrink, P. Sprøgel, Knud Kragballe, Ortonne Jp, H. Kupper, H-U Esslinger, Petr Arenberger

المصدر: Thaçi, D, Ortonne, J-P, Chimenti, S, Ghislain, P-D, Arenberger, P, Kragballe, K, Saurat, J-H, Khemis, A, Sprøgel, P, Esslinger, H-U, Unnebrink, K & Kupper, H 2010, ' A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study ', British Journal of Dermatology, vol. 163, no. 2, pp. 402-11 . https://doi.org/10.1111/j.1365-2133.2010.09791.xTest

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Combination therapy, Administration, Topical, Anti-Inflammatory Agents, Dermatology, Antibodies, Monoclonal, Humanized, Betamethasone, Severity of Illness Index, law.invention, Medication Adherence, chemistry.chemical_compound, Randomized controlled trial, Calcitriol, Double-Blind Method, law, Psoriasis Area and Severity Index, Internal medicine, Psoriasis, Clinical endpoint, Adalimumab, medicine, Humans, Calcipotriol, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Surgery, Europe, chemistry, Drug Therapy, Combination, Female, Dermatologic Agents, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a47bbe652f190f18268ad7246ef6010Test
https://pubmed.ncbi.nlm.nih.gov/20377585Test

المؤلفون: James Ford, Naoya Yamazaki, Marine Weill, Pascal Wolter, Mario Mandalà, Giovanni Rangoni, Lev V. Demidov, Paolo A. Ascierto, Georgina V. Long, Petr Arenberger, Ernesto Wasserman, Keith T. Flaherty, Dirk Schadendorf, Reinhard Dummer, Anna Maria Di Giacomo

المصدر: Cancer Research. 75:B16-B16

مصطلحات موضوعية: Oncology, Neuroblastoma RAS viral oncogene homolog, Cancer Research, medicine.medical_specialty, business.industry, MEK inhibitor, Melanoma, Dacarbazine, Cancer, Binimetinib, medicine.disease, Surgery, chemistry.chemical_compound, chemistry, Internal medicine, Cutaneous melanoma, Clinical endpoint, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::75dbe24a3fa72f395e54723fe4089803Test
https://doi.org/10.1158/1538-7445.mel2014-b16Test

المؤلفون: R. Dummer, Keith T. Flaherty, Naoya Yamazaki, Pascal Wolter, Matthew H. Taylor, John Ford, P.A. Ascierto, Dirk Schadendorf, Alexander Starodub, Petr Arenberger, Georgina V. Long, Ernesto Wasserman, J.W.B. de Groot, Michal Lotem, Maria Marples, Marine Weill, Sigrun Hallmeyer

المصدر: Annals of Oncology. 25:iv392

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, Oncology, medicine.medical_specialty, Performance status, business.industry, Dacarbazine, MEK inhibitor, Binimetinib, Hematology, Surgery, chemistry.chemical_compound, chemistry, Internal medicine, Cutaneous melanoma, medicine, Clinical endpoint, Progression-free survival, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d25c3033b4691c3fc6d2763ab1393bffTest
https://doi.org/10.1093/annonc/mdu344.46Test